Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)

BACKGROUND: Healthcare decision makers need to make trade-offs between different elements of value of new treatments. Multicriteria decision analysis (MCDA) provides a framework that can help decision makers to understand stakeholders’ preferences and be explicit about the trade-offs that are being...

Descripción completa

Detalles Bibliográficos
Autores principales: Garau, Martina, Hampson, Grace, Devlin, Nancy, Mazzanti, Nicola Amedeo, Profico, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972119/
https://www.ncbi.nlm.nih.gov/pubmed/29623625
http://dx.doi.org/10.1007/s41669-017-0048-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972119/
https://www.ncbi.nlm.nih.gov/pubmed/29623625
http://dx.doi.org/10.1007/s41669-017-0048-x

Ejemplares similares